Adjuvanted-RSVPreF3 vaccine uptake and effectiveness in individuals with COPD: a nationwide Danish cohort study
Adjuvanted-RSVPreF3 is highly effective in preventing RSV hospitalization in individuals aged ≥60 years with COPD. Disease outcomes could be improved by incorporating RSV vaccination into routine COPD management.
Authors
- Foteini Gkalapi (ORCID: https://orcid.org/0000-0002-5611-6374)
- Katherine Theiss-Nyland (ORCID: https://orcid.org/0000-0001-6585-7847)
- Maria Spanggaard
- Jørgen Vestbo
- Yunus Çolak
- Kasper Løwe Lundgren
- Sara Burns
- Stanislava Bratković
- María Solano Fonseca
Institutions
- Parthenope University of Naples (IT)
- Central Party School of the Communist Party of China (CN)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
- Rigshospitalet (DK)
- University of Manchester (GB)
Publication Details
- Journal
- Expert Review of Vaccines
- Published
- 2026-03-05
- DOI
- https://doi.org/10.1080/14760584.2026.2641671
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00